CasNo.14636-12-5,Terlipressin Acetate,(14636-12-5) Suppliers

10 Milligram	Negotiable

Min.Order :10 Milligram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T

Keywords

Terlipressin Terlipressin Acetate 14636-12-5

Quick Details

Appearance:white powder
Application:Terlipressin Acetate
PackAge:Vial or customized
ProductionCapacity:100|Kilogram|Month
Storage:2-8℃ sealed and away from light
Transportation:Ocean and air shipping

Superiority:

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

Terlipressin Acetate exerts a potent vasoconstrictive effect, primarily targeting the splanchnic circulation. By constricting the blood vessels in the splanchnic area, it effectively reduces portal blood flow and portal pressure. This property is of great value in the management of variceal bleeding, a life - threatening complication commonly associated with liver cirrhosis. Clinical studies have demonstrated its high success rate in controlling acute variceal bleeding, thereby significantly improving patient survival rates and reducing the need for invasive procedures.

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Details:

Terlipressin Acetate:
CAS No. : 14636-12-5
Peptide Sequence:
Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2(Disulfide bridge: Cys4-Cys9)

Terlipressin acetate is a vasopressin analog with potent vasoactive properties, which can reduce visceral blood flow and portal pressure and control acute varicose rupture bleeding. Terlipressin acetate can be used to treat hepatorenal syndrome as well.

Product Name	Terlipressin Acetate
CAS NO.	14636-12-5
Appearance	White Powder
Purity	99% or customized
Application	Drug peptides
Usage	Terlipressin acetate can reduce visceral blood flow and portal pressure and control acute varicose rupture bleeding, used to treat hepatorenal syndrome as well.

Company Profile

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.